Linghua Li

InstitutionGuangzhou Medical University
AddressGuangzhou
Guangdong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in October 2020
    All Publications
    Bar chart showing 27 publications over 8 distinct years, with a maximum of 9 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Liao B, Liu Z, Tang L, Li L, Gan Q, Shi H, Jiao Q, Guan Y, Xie M, He X, Zhao H, Chen W, Liu Y, Li L, Wang Y, Cao Y, Shi Y, Li Y, Lei C. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci. 2021; 18(1):29-41. PMID: 33390771.
      Citations: 4     Fields:    Translation:Humans
    2. Lei C, Lin W, Deng X, Hu F, Chen F, Cai W, Li Y, Wen C, Guan Y, Wang J, Chen X, Cao Y, Li F, Tang X, Li L. Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China. J Clin Virol. 2020 12; 133:104661. PMID: 33096290.
      Citations: 2     Fields:    Translation:Humans
    3. Hu F, Chen F, Ou Z, Fan Q, Tan X, Wang Y, Pan Y, Ke B, Li L, Guan Y, Mo X, Wang J, Wang J, Luo C, Wen X, Li M, Ren P, Ke C, Li J, Lei C, Tang X, Li F. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol. 2020 11; 17(11):1119-1125. PMID: 33037400.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    4. Huang H, Cai S, Li Y, Li Y, Fan Y, Li L, Lei C, Tang X, Hu F, Li F, Deng X. Prognostic Factors for COVID-19 Pneumonia Progression to Severe Symptoms Based on Earlier Clinical Features: A Retrospective Analysis. Front Med (Lausanne). 2020; 7:557453. PMID: 33123541.
      Citations: 25     
    5. Li L, Liang Y, Hu F, Yan H, Li Y, Xie Z, Huang L, Zhao J, Wan Z, Wang H, Shui J, Cai W, Tang S. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients. Virology. 2020 12; 551:26-35. PMID: 33011520.
      Citations: 7     Fields:    Translation:Humans
    6. Lin W, Xie Z, Li Y, Li L, Wen C, Cao Y, Chen X, Ou X, Hu F, Li F, Tang X, Cai W, Li L. Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. J Med Virol. 2021 02; 93(2):794-802. PMID: 32672840.
      Citations: 16     Fields:    Translation:Humans
    7. Lin YF, Duan Q, Zhou Y, Yuan T, Li P, Fitzpatrick T, Fu L, Feng A, Luo G, Zhan Y, Liang B, Fan S, Lu Y, Wang B, Wang Z, Zhao H, Gao Y, Li M, Chen D, Chen X, Ao Y, Li L, Cai W, Du X, Shu Y, Zou H. Spread and Impact of COVID-19 in China: A Systematic Review and Synthesis of Predictions From Transmission-Dynamic Models. Front Med (Lausanne). 2020; 7:321. PMID: 32626719.
      Citations: 13     
    8. Wang Y, Liao B, Guo Y, Li F, Lei C, Zhang F, Cai W, Hong W, Zeng Y, Qiu S, Wang J, Li Y, Deng X, Li J, Xiao G, Guo F, Lai X, Liang Z, Wen X, Li P, Jiao Q, Xiang F, Wang Y, Ma C, Xie Z, Lin W, Wu Y, Tang X, Li L, Guan Y. Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China. Open Forum Infect Dis. 2020 Jun; 7(6):ofaa187. PMID: 32577426.
      Citations: 16     
    9. Li Y, Xie Z, Lin W, Cai W, Wen C, Guan Y, Mo X, Wang J, Wang Y, Peng P, Chen X, Hong W, Xiao G, Liu J, Zhang L, Hu F, Li F, Zhang F, Deng X, Li L. Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med (N Y). 2020 Dec 18; 1(1):105-113.e4. PMID: 32838353.
      Citations: 115     
    10. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020 06; 80(6):656-665. PMID: 32283155.
      Citations: 306     Fields:    Translation:HumansPHPublic Health